Laster Wr
About
In The Last Decade
Laster Wr
28 papers receiving 996 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Oncology 574
- Molecular Biology 433
- Pulmonary and Respiratory Medicine 242
- Surgery 126
- Cancer Research 125
Countries citing papers authored by Laster Wr
This map shows the geographic impact of Laster Wr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laster Wr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laster Wr more than expected).
Fields of papers citing papers by Laster Wr
This network shows the impact of papers produced by Laster Wr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laster Wr. The network helps show where Laster Wr may publish in the future.
Co-authorship network of co-authors of Laster Wr
This figure shows the co-authorship network connecting the top 25 collaborators of Laster Wr. A scholar is included among the top collaborators of Laster Wr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laster Wr. Laster Wr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Antitumor activity of ethyl 5-amino-1,2-dihydro-2-methyl-3-phenyl-pyrido [3,4-b]pyrazin-7-ylcarbamate, 2-hydroxyethanesulfonate, hydrate (NSC 370147) against selected tumor systems in culture and in mice. | 20 |
| 2 | Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. | 25 |
| 3 | Establishment of cross-resistance profiles for new agents. | 92 |
| 4 | Reversal of methotrexate toxicity in mice by a calcium salt of citrovorum factor and related compounds. | 3 |
| 5 | cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. breakdown → | 357 |
| 6 | Concepts for controlling drug-resistant tumor cells. | 43 |
| 7 | Evaluation of whole-body hyperthermia as an adjunct to chemotherapy in murine tumors. | 23 |
| 8 | Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors. | 7 |
| 9 | Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU. | 3 |
| 10 | Experimental studies of the antitumor activity of amygdalin MF (NSC-15780) alone and in combination with beta-glucosidase (NSC-128056). | 15 |
| 11 | Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971. | 23 |
| 12 | Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy. | 23 |
| 13 | Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia. | 23 |
| 14 | Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774). | 4 |
| 15 | Experimental evaluation of potential anticancer agents. XX. Development of immunity to leukemia L1210 in BDF mice and effects of therapy. | 11 |
| 16 | Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. | 35 |
| 17 | Experimental evaluation of potential anticancer agents. X. A specificity test for distinguishing false positives. | 2 |
| 18 | Experimental evaluation of potential anticancer agents VIII. Effects of certain nitrosoureas on intracerebral L1210 leukemia. | 257 |
| 19 | Experimental evaluation of potential anticancer agents. II. Studies on the growth characteristics, metastases, and drug response of hamster neoplasms of diverse "sites of origin". | 7 |
| 20 | Experimental evaluation of potential anticancer agents. I. Quantitative therapeutic evaluation of certain purine analogs. | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.